Sulfur(vi) fluoride exchange as a key reaction for synthesizing biaryl sulfate core derivatives as potent hepatitis C virus NS5A inhibitors and their structure–activity relationship studies
出版年份 2018 全文链接
标题
Sulfur(vi) fluoride exchange as a key reaction for synthesizing biaryl sulfate core derivatives as potent hepatitis C virus NS5A inhibitors and their structure–activity relationship studies
作者
关键词
-
出版物
RSC Advances
Volume 8, Issue 55, Pages 31803-31821
出版商
Royal Society of Chemistry (RSC)
发表日期
2018-09-12
DOI
10.1039/c8ra05471a
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Design, synthesis and identification of silicon-containing HCV NS5A inhibitors with pan-genotype activity
- (2018) Baomin Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Highlights of the Structure–Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530)
- (2018) Rolf Wagner et al. JOURNAL OF MEDICINAL CHEMISTRY
- New potent biaryl sulfate-based hepatitis C virus inhibitors
- (2017) Youngsu You et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Nucleophilic Deoxyfluorination of Phenols via Aryl Fluorosulfonate Intermediates
- (2017) Sydonie D. Schimler et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Bifluoride-catalysed sulfur(VI) fluoride exchange reaction for the synthesis of polysulfates and polysulfonates
- (2017) Bing Gao et al. Nature Chemistry
- SuFEx: a metal-free click ligation for multivalent biomolecules
- (2017) Alessandro Dondoni et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- SuFEx Click: New Materials from SO x F and Silyl Ethers
- (2016) Jeremy Yatvin et al. CHEMISTRY-A EUROPEAN JOURNAL
- A Click Ligation Based on SuFEx for the Metal-Free Synthesis of Sugar and Iminosugar Clusters
- (2016) Renaud Zelli et al. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response
- (2016) Norah A. Terrault et al. GASTROENTEROLOGY
- Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Polymorphisms
- (2016) Ling Tong et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Potent, Selective, and Orally Bioavailable HCV NS5A Inhibitor for Treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazol-2-yl)pyrrolidine-2-carboxamide
- (2016) Iou-Jiun Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- 2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry Triumph
- (2016) Nicholas A. Meanwell JOURNAL OF MEDICINAL CHEMISTRY
- Recent Advances in Antiviral Therapy for Chronic Hepatitis C
- (2016) Akihiro Tamori et al. MEDIATORS OF INFLAMMATION
- An atom-efficient and convergent approach to the preparation of NS5A inhibitors by C–H activation
- (2016) Thomas O. Moore et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Direct introduction of R-SO2F moieties into proteins and protein-polymer conjugation using SuFEx chemistry
- (2016) Shaohua Li et al. POLYMER
- New direct-acting antivirals in hepatitis C therapy: a review of sofosbuvir, ledipasvir, daclatasvir, simeprevir, paritaprevir, ombitasvir and dasabuvir
- (2016) Sean M. McConachie et al. Expert Review of Clinical Pharmacology
- SuFEx on the Surface: A Flexible Platform for Postpolymerization Modification of Polymer Brushes
- (2015) Jeremy Yatvin et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 1: C2-Symmetric inhibitors with diyne and biphenyl linkers
- (2015) Simon Giroux et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 2: Non-symmetric inhibitors with potent activity against genotype 1a and 1b
- (2015) Simon Giroux et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and evaluation of NS5A inhibitors containing diverse heteroaromatic cores
- (2015) James A. Henderson et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Daclatasvir: A Review of Its Use in Adult Patients with Chronic Hepatitis C Virus Infection
- (2015) Paul L. McCormack DRUGS
- Novel benzidine and diaminofluorene prolinamide derivatives as potent hepatitis C virus NS5A inhibitors
- (2015) Il Hak Bae et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Applications of Fluorine in Medicinal Chemistry
- (2015) Eric P. Gillis et al. JOURNAL OF MEDICINAL CHEMISTRY
- Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5A
- (2015) Jin-Hua Sun et al. NATURE
- Combination of AGET ATRP and SuFEx for post-polymerization chain-end modifications
- (2015) Shaohua Li et al. POLYMER
- Sulfonyl fluorides as privileged warheads in chemical biology
- (2015) Arjun Narayanan et al. Chemical Science
- Sulfur(VI) Fluoride Exchange (SuFEx): Another Good Reaction for Click Chemistry
- (2014) Jiajia Dong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- SuFEx-Based Synthesis of Polysulfates
- (2014) Jiajia Dong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Comparison of Daclatasvir Resistance Barriers on NS5A from Hepatitis C Virus Genotypes 1 to 6: Implications for Cross-Genotype Activity
- (2014) Chunfu Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Update on hepatitis C virus resistance to direct-acting antiviral agents
- (2014) Eva Poveda et al. ANTIVIRAL RESEARCH
- Current race in the development of DAAs (direct-acting antivirals) against HCV
- (2014) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Discovery of functionalized bisimidazoles bearing cyclic aliphatic-phenyl motifs as HCV NS5A inhibitors
- (2014) Min Zhong et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Potent bisimidazole-based HCV NS5A inhibitors bearing annulated tricyclic motifs
- (2014) Min Zhong et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Hepatitis C virus NS5A: enigmatic but still promiscuous 10 years on!
- (2014) D. Ross-Thriepland et al. JOURNAL OF GENERAL VIROLOGY
- Novel Spiroketal Pyrrolidine GSK2336805 Potently Inhibits Key Hepatitis C Virus Genotype 1b Mutants: From Lead to Clinical Compound
- (2014) Wieslaw M. Kazmierski et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons
- (2014) Makonen Belema et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Development of Hepatitis C Virus NS5A Replication Complex Inhibitors
- (2014) Makonen Belema et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Highly Potent Hepatitis C Virus NS5A Inhibitor (AV4025)
- (2014) Alexandre V. Ivachtchenko et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect
- (2014) Makonen Belema et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A
- (2014) David A. DeGoey et al. JOURNAL OF MEDICINAL CHEMISTRY
- Asymmetric Binding to NS5A by Daclatasvir (BMS-790052) and Analogs Suggests Two Novel Modes of HCV Inhibition
- (2014) James H. Nettles et al. JOURNAL OF MEDICINAL CHEMISTRY
- Treatment of hepatitis C: Perspectives
- (2014) S. Pol et al. MEDECINE ET MALADIES INFECTIEUSES
- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- (2014) Mark S. Sulkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance Patterns Associated with HCV NS5A Inhibitors Provide Limited Insight into Drug Binding
- (2014) Moheshwarnath Issur et al. Viruses-Basel
- Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA
- (2014) David B. Ascher et al. Scientific Reports
- Antiviral treatment of hepatitis C
- (2014) E. R. Feeney et al. BMJ-British Medical Journal
- Synthesis and evaluation of non-dimeric HCV NS5A inhibitors
- (2013) Franck Amblard et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- HCV NS5A replication complex inhibitors. Part 5: Discovery of potent and pan-genotypic glycinamide cap derivatives
- (2013) Makonen Belema et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of MK-8742: An HCV NS5A Inhibitor with Broad Genotype Activity
- (2013) Craig A. Coburn et al. ChemMedChem
- New horizons in hepatitis C antiviral therapy with direct-acting antivirals
- (2013) Alessio Aghemo et al. HEPATOLOGY
- HCV NS5A Replication Complex Inhibitors. Part 4.1 Optimization for Genotype 1a Replicon Inhibitory Activity
- (2013) Denis R. St. Laurent et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection
- (2013) John O. Link et al. JOURNAL OF MEDICINAL CHEMISTRY
- Future therapies for chronic hepatitis C
- (2013) Noura M. Dabbouseh et al. Nature Reviews Gastroenterology & Hepatology
- Characterizations of HCV NS5A replication complex inhibitors
- (2013) Donald R. O'Boyle II et al. VIROLOGY
- Discovery of Thienoimidazole-Based HCV NS5A Genotype 1a and 1b Inhibitors
- (2013) Simon Giroux et al. ACS Medicinal Chemistry Letters
- Potent Hepatitis C Virus NS5A Inhibitors Containing a Benzidine Core
- (2013) Il Hak Bae et al. ACS Medicinal Chemistry Letters
- Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
- (2012) Jennifer J. Kiser et al. Annual Review of Pharmacology and Toxicology
- Hepatitis C Virus RNA Elimination and Development of Resistance in Replicon Cells Treated with BMS-790052
- (2012) Chunfu Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and biological evaluation of new potent and selective HCV NS5A inhibitors
- (2012) Junxing Shi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- HCV NS5A replication complex inhibitors. Part 3: discovery of potent analogs with distinct core topologies
- (2012) Omar D. Lopez et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Interferon-Free Hepatitis C Therapy
- (2012) Paul J. Pockros DRUGS
- Correlation between NS5A Dimerization and Hepatitis C Virus Replication
- (2012) Precious J. Lim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Drugs in development for chronic hepatitis C: a promising future
- (2011) Paul J Pockros EXPERT OPINION ON BIOLOGICAL THERAPY
- Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1
- (2011) Richard E. Nettles et al. HEPATOLOGY
- Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations
- (2011) Robert A. Fridell et al. HEPATOLOGY
- Small Molecules Targeting Hepatitis C Virus-Encoded NS5A Cause Subcellular Redistribution of Their Target: Insights into Compound Modes of Action
- (2011) P. Targett-Adams et al. JOURNAL OF VIROLOGY
- Therapeutics: New drugs hit the target
- (2011) Jana Schlütter NATURE
- New Merck and Vertex drugs raise standard of care in hepatitis C
- (2011) Cormac Sheridan NATURE BIOTECHNOLOGY
- Hepatitis C: move over interferon
- (2011) Ken Garber NATURE BIOTECHNOLOGY
- Generation of a Cell Culture-Adapted Hepatitis C Virus with Longer Half Life at Physiological Temperature
- (2011) Chon Saeng Kim et al. PLoS One
- Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes
- (2011) Jeffrey L. Romine et al. ACS Medicinal Chemistry Letters
- Receptor activity and conformational analysis of 5′-halogenated resiniferatoxin analogs as TRPV1 ligands
- (2010) Kwang Su Lim et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Drugs for Hepatitis C: Unlocking a New Mechanism of Action
- (2010) Thomas W. Bell ChemMedChem
- The C-Terminal -Helix Domain of Apolipoprotein E Is Required for Interaction with Nonstructural Protein 5A and Assembly of Hepatitis C Virus
- (2010) W. Cun et al. JOURNAL OF VIROLOGY
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- Assembly of infectious hepatitis C virus particles
- (2010) Ralf Bartenschlager et al. TRENDS IN MICROBIOLOGY
- Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus
- (2009) R. A. Love et al. JOURNAL OF VIROLOGY
- The global burden of hepatitis C
- (2009) Daniel Lavanchy LIVER INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search